Tamsulosin Hydrochloride Capsule
Product Images NDC 43063-725

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 43063-725). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063725 Label (43063725)

This is a label for a medication called Tamsulosin. Each bottle contains 90 capsules with 0.4mg per capsule. It has lot numbers and an expiration date of 12/2023. The label provides directions to take the medication by mouth, 1 capsule, multiple times a day. In case of side effects, patients are advised to call their doctor or report it to the FDA. There is additional text on the label that is unreadable due to errors.*

FDA Label Image

Figure 1 Mean Plasma Tamsulosin Hydrochloride Concentrations Following Single-dose Administration Of Tamsulosin Hydrochloride Capsules 0.4 mg Under Fasted And Fed Conditions (n=8) (Tamsulosin Fig1)

The text appears to be a figure caption or description for a graph showing the mean plasma concentration of tamsulosin hydrochloride at different time points after a single dose of 0.4 mg under fasted and fed conditions. However, the figure itself and more context is needed to provide a more complete description.*

FDA Label Image

Figure 2a Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 1 (Tamsulosin Fig2)

FDA Label Image

Figure 2b Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 2 (Tamsulosin Fig3)

This is a figure showing the mean change from baseline in total AUA symptom score (ranging from 0 to 35) for different treatments in Study 2. The treatments include O-O-0.08mg LNt, 0.4mg, and placebo. The figure also includes the duration of treatment in weeks. No further information is provided.*

FDA Label Image

Figure 3a Mean Increase In Peak Urine Flow Rate (ml/sec) Study 1 (Tamsulosin Fig4)

This is a figure (Figure 3A) displaying the mean increase in peak urine flow rate in L/Sec for study 1. The x-axis represents the duration of treatment in weeks, while the y-axis represents the mean change in mL/sec in peak urine flow rate. The treatment groups are represented by symbols on the graph: 25 -O—O-—0-08mg, -A-=A=2x 0.4mg, and FPlacebo. There are also numerical values for the mean change in peak urine flow rate in mL/sec for each of the treatment groups at different time points (7, 10, 13, and LOGF [not sure what this means]). The number of people in each treatment group is also listed in parentheses next to the time points.*

FDA Label Image

Figure 3b Mean Increase In Peak Urine Flow Rate (ml/sec) Study 2 (Tamsulosin Fig5)

This text is a figure caption showing the mean increase in peak urine flow rate in Study 2 over the course of treatment in weeks. Specific values are not available in the text.*

FDA Label Image

Chemical Structure (Tamsulosin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.